Qiagen to launch rapid COVID-19 blood test in U.S.

QIAGEN (NYSE:QGEN) announces the U.S. launch of its Access Anti-SARS-CoV-2 Total test for the detection of SARS-CoV-2 antibodies in serum or plasma.

The rapid 10-minute assay is performed on the portable eHub digital device that can process up to 32 tests per hour.

The company says the test has 100% sensitivity (correctly identifying true positives) and 100% specificity (correctly identifying true negatives).

https://seekingalpha.com/news/3608352-qiagen-to-launch-rapid-covidminus-19-blood-test-in-u-s